← brief for 2026-10-20 · Slowing decline

Real-world renoprotective effects of polyethylene glycol-loxenatide in type 2 diabetes: a multicenter, ambispective cohort study.

Article C Peer reviewed Observational

Key takeaways

This large study followed 3,305 people with type 2 diabetes and kidney issues. It looked at a drug called polyethylene glycol-loxenatide. It is a cohort study, so it shows a link, not proof of cause. The drug appeared to protect kidneys in the real world.

Who did this work

Ye J · Li J · Chen Y · Chen F · Zhu D · Zhang C · Chen Q · Tian Y · Yang S · Xu W · Xie B · Chen ZS

Source

Article · PubMed, CKD progression and prevention · 2026 Oct 20
https://pubmed.ncbi.nlm.nih.gov/42897130/